Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medical Net Inc. (3645:JPX), powered by AI.
Medical Net Inc. is currently trading at ¥231. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Medical Net Inc. on Alpha Lenz.
Medical Net Inc.'s P/E ratio is -30.2.
“Medical Net Inc. trades at a P/E of -30.2 (undervalued) with modest ROE of -3.8%. 3Y revenue CAGR of 17.5% highlights clear growth momentum.”
Ask for details →Medical Net Inc. is a prominent player in the healthcare technology sector, specializing in digital health solutions that enhance patient care and streamline healthcare operations. The company develops comprehensive software and IT systems designed for hospitals, clinics, and medical institutions, providing platforms for electronic health records, telemedicine services, and data analytics. Medical Net Inc. plays a crucial role in modernizing the healthcare infrastructure, enabling more efficient patient management and facilitating improved communication between healthcare providers and patients. Its innovative solutions are pivotal in reducing administrative burdens and optimizing workflow processes, ultimately contributing to better patient outcomes and increased operational efficiency for healthcare providers. By leveraging cutting-edge technology and robust data security measures, Medical Net Inc. ensures high-quality service delivery and compliance with sensitive health information regulations. The company's contributions are significant in an era where digital transformation is critical to addressing healthcare challenges globally.
“Medical Net Inc. trades at a P/E of -30.2 (undervalued) with modest ROE of -3.8%. 3Y revenue CAGR of 17.5% highlights clear growth momentum.”
Ask for details →Medical Net Inc. (ticker: 3645) is a company listed on JPX in the Communication Services sector (Internet Content & Information). It has approximately 296 employees. Market cap is $2.1B.
The current price is 231 with a P/E ratio of -30.24x and P/B of 1.2x.
ROE is -3.76% and operating margin is 1.63%. Annual revenue is $6.1B.